How Quality Control Systems AID Sec-Dependent Protein Translocation
Overview
Authors
Affiliations
The evolutionarily conserved Sec machinery is responsible for transporting proteins across the cytoplasmic membrane. Protein substrates of the Sec machinery must be in an unfolded conformation in order to be translocated across (or inserted into) the cytoplasmic membrane. In bacteria, the requirement for unfolded proteins is strict: substrate proteins that fold (or misfold) prematurely in the cytoplasm prior to translocation become irreversibly trapped in the cytoplasm. Partially folded Sec substrate proteins and stalled ribosomes containing nascent Sec substrates can also inhibit translocation by blocking (i.e., "jamming") the membrane-embedded Sec machinery. To avoid these issues, bacteria have evolved a complex network of quality control systems to ensure that Sec substrate proteins do not fold in the cytoplasm. This quality control network can be broken into three branches, for which we have defined the acronym "AID": (i) of cytoplasmic intermediates through cotranslationally channeling newly synthesized Sec substrates to the Sec machinery; (ii) of folding Sec substrate proteins that transiently reside in the cytoplasm by molecular chaperones and the requirement for posttranslational modifications; (iii) of products that could potentially inhibit translocation. In addition, several stress response pathways help to restore protein-folding homeostasis when environmental conditions that inhibit translocation overcome the AID quality control systems.
TerC proteins function during protein secretion to metalate exoenzymes.
He B, Sachla A, Helmann J Nat Commun. 2023; 14(1):6186.
PMID: 37794032 PMC: 10550928. DOI: 10.1038/s41467-023-41896-1.
A unifying mechanism for protein transport through the core bacterial Sec machinery.
Allen W, Collinson I Open Biol. 2023; 13(8):230166.
PMID: 37643640 PMC: 10465204. DOI: 10.1098/rsob.230166.
The biogenesis of β-lactamase enzymes.
Kaderabkova N, Bharathwaj M, Furniss R, Gonzalez D, Palmer T, Mavridou D Microbiology (Reading). 2022; 168(8).
PMID: 35943884 PMC: 10235803. DOI: 10.1099/mic.0.001217.
Current trends in biopharmaceuticals production in Escherichia coli.
McElwain L, Phair K, Kealey C, Brady D Biotechnol Lett. 2022; 44(8):917-931.
PMID: 35796852 DOI: 10.1007/s10529-022-03276-5.
Strategies to Enhance Periplasmic Recombinant Protein Production Yields in .
Karyolaimos A, Gier J Front Bioeng Biotechnol. 2021; 9:797334.
PMID: 34970535 PMC: 8712718. DOI: 10.3389/fbioe.2021.797334.